Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV001644614 | SCV000615172 | uncertain significance | not provided | 2020-09-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002438248 | SCV002754299 | uncertain significance | Inborn genetic diseases | 2020-01-06 | criteria provided, single submitter | clinical testing | The p.T1008S variant (also known as c.3023C>G), located in coding exon 8 of the SETX gene, results from a C to G substitution at nucleotide position 3023. The threonine at codon 1008 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003233675 | SCV003931478 | uncertain significance | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233676 | SCV003931479 | uncertain significance | Amyotrophic lateral sclerosis type 4 | 2023-02-08 | criteria provided, single submitter | clinical testing |